Lv21
105 积分 2021-04-25 加入
Trends in target novelty in oncology R&D
7小时前
待确认
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
1个月前
已完结
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
2个月前
已完结
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories
2个月前
已完结
Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice
2个月前
已完结
Evaluation of multiple immunoassay formats for detection of anti-drug antibodies to zinpentraxin alfa
2个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
3个月前
已完结
The race to reset autoimmune diseases
3个月前
已完结
Assessing linearity of vaccine immunogenicity assays: application and link with clinical endpoints
3个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
4个月前
已完结
皖公网安备34019202002308
